A01N45/00

Tiglien-3-one derivatives

The present invention relates to tiglien-3-one compounds and their use in methods of treating or preventing protozoal infections, bacterial infections, parasitic infections and cell proliferative disorders. The tiglien-3-one compounds are also used in methods of controlling pests in humans, animals, plants and the environment

Non-aqueous solution of plant-growth regulator(s) and polar and/or semi-polar organic solvent(s)

The present invention generally relates to non-aqueous solutions of plant growth regulator(s) and polar and/or semi-polar organic solvent(s), methods for making said non-aqueous solution, and methods for improving the growth and crop productivity of plants using said non-aqueous solution.

Non-aqueous solution of plant-growth regulator(s) and polar and/or semi-polar organic solvent(s)

The present invention generally relates to non-aqueous solutions of plant growth regulator(s) and polar and/or semi-polar organic solvent(s), methods for making said non-aqueous solution, and methods for improving the growth and crop productivity of plants using said non-aqueous solution.

SMART RELEASE POTASH FERTILIZER GRANULES

There is provided a smart release potash fertilizer granule comprising a potash core; an extended release layer covering the potash core, wherein the extended release layer comprises water-swellable copolymeric nanoparticles and at least one water-soluble organic acid or water-soluble organic carboxylate salt; a controlled release layer covering the extended release layer, wherein the controlled release layer comprises water-swellable copolymeric nanoparticles; and an anticaking layer covering the controlled release layer, wherein the anticaking layer comprises water-insoluble copolymeric nanoparticles.

SMART RELEASE POTASH FERTILIZER GRANULES

There is provided a smart release potash fertilizer granule comprising a potash core; an extended release layer covering the potash core, wherein the extended release layer comprises water-swellable copolymeric nanoparticles and at least one water-soluble organic acid or water-soluble organic carboxylate salt; a controlled release layer covering the extended release layer, wherein the controlled release layer comprises water-swellable copolymeric nanoparticles; and an anticaking layer covering the controlled release layer, wherein the anticaking layer comprises water-insoluble copolymeric nanoparticles.

Use of cationic steroidal antimicrobials for sporicidal activity
10959433 · 2021-03-30 · ·

This disclosure relates to sporicidal compositions and uses thereof. The sporicidal compositions include one or more cationic steroidal antimicrobials (CSAs). The sporicidal compositions may be applied to an object to kill or deactivate bacterial spores contacting the sporicidal composition. The object may be a food product, food processing equipment, industrial equipment, or healthcare facility objects. The sporicidal composition may be administered to a subject that has, is suspected to have, or is at risk for an infection associated with spore-forming bacteria.

Use of cationic steroidal antimicrobials for sporicidal activity
10959433 · 2021-03-30 · ·

This disclosure relates to sporicidal compositions and uses thereof. The sporicidal compositions include one or more cationic steroidal antimicrobials (CSAs). The sporicidal compositions may be applied to an object to kill or deactivate bacterial spores contacting the sporicidal composition. The object may be a food product, food processing equipment, industrial equipment, or healthcare facility objects. The sporicidal composition may be administered to a subject that has, is suspected to have, or is at risk for an infection associated with spore-forming bacteria.

Methods of treating SARS-COV-2 infections
10905698 · 2021-02-02 · ·

The disclosure is directed to methods of using TUDCA, or a pharmaceutically acceptable salt thereof, or a derivative thereof, for the treatment of SARS-CoV-2 infections.

Methods of treating SARS-COV-2 infections
10905698 · 2021-02-02 · ·

The disclosure is directed to methods of using TUDCA, or a pharmaceutically acceptable salt thereof, or a derivative thereof, for the treatment of SARS-CoV-2 infections.

USE OF DELAYED DORMANT APPLICATIONS OF HOMOBRASSINOLIDE ON GRAPES TO ENHANCE BUD BREAK
20210022339 · 2021-01-28 ·

We disclose methods to enhance bud breaking in grapes. Unfavorable bud breaking is caused by insufficient dormancy, which itself is commonly caused by insufficiently cold or long winters. Insufficient dormancy results in apical dominance which lessens the number of branches and fruiting sites. We have discovered that treatment with the plant growth regulator homobrassinolide enhances great growth uniformity and bud-break uniformity similar to Hydrogen Cyanamide without the negative effects.